Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Immix Biopharma Inc increased its cash reserves by 30.31%, or 4.07m. Cash Flow from Financing totalled 15.46m or -- of revenues. In addition the company used 11.37m for operations while cash used for investing totalled 52.09k.
Cash flow per share | -0.8306 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.871 |
---|---|
Tangible book value per share | 0.871 |
More ▼
Balance sheet in USDView more
Current ratio | 7.00 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼